Skip to main content
. 2020 Mar 19;20:231. doi: 10.1186/s12879-020-4883-5

Table 2.

The proportion of C. albicans to NAC species and the first 3 dominant Candida species isolated in the current study compared to earlier studies between and with countries

Clinical sample Country Reference
No, isolates C. albicans, n (%) NAC n (%) Dominate species
194* 104(49.8%) 90 (43.1%) Various Ethiopia C. albicans, C. krusei, C. fabata *
177 139(78.5) 38(21.5) Oral (HIV patients Ethiopia C. albicans, C. glabrata,C. tropicalis Mulu et al, 2013 [16]
81 51(58.6) 30(41.4) Vaginal swab Ethiopia C. albicans, C. krusei,C. dubliniesis Bitew and Abebaw, 2018 [17]
63 38(60.3) 25(39.7) Vaginal swab Egypt C. albicans, C. glabrata, C. krusei ElFeky et al, 2016 [18]
111 44(39.6) 67(60.4) Various India C. albicans, C. krusei, C tropicalis Mohandas & Balla 2011 [19]
90 33(36.7) 57(63.3) Various India C. albicans, C. tropicalis,C. parapsilosis Das et al 2016 [20]
102 37(36.3) 65(63.7) Various India C. tropicalis, C. albicans.C. guilliermondii Sida et al, 2017 [21]
250 154(61.6) 96(38.4) Oral cavity Thailand C. albicans, C. glabrata, C. tropicalis Muadcheingka&Tantivitayakul,2015 [22]
108 61(56.5) 47(43.5) Blood Taiwan C. albicans, C. glabrata, C. tropicalis Chi et al,2011 [23]
90 33(36.7) 57(63.3) Various India C. tropicalis, C.albicans. C. glabrata Kaur et al, 2016 [24]
103 80(77.8) 23(22.3) Oral (HIV patients) Brazil C.albicans, C. tropicalis, C. parapsilosis Ribeiro, et al, 2015 [25]
1062 573(54) 489 (46) Various Germany &Austria C. albicans, C. glabrata, C. parapsilosis Schmalreck et al, 2012 [26]
580 420(72.4) 160(27.6) Vaginal swab America C. albicans, C. glabrata, C. parapsilosis Richter et al, 2005 [27]
428 273(63.8) 155(36.2) Various Iran C. albicans. C. tropicalis, C. parapsilosis Badiee et al, 2011 [28]
103 43(42) 60(58) Blood Latin America C. albicans. C. tropicalis, C. parapsilosis Godoy et al, 2003 [29]

* = current study